[HTML][HTML] Tumor Biology Hides Novel Therapeutic Approaches to Diffuse Large B-Cell Lymphoma: A Narrative Review
R Masnikosa, Z Cvetković, D Pirić - International Journal of Molecular …, 2024 - mdpi.com
Diffuse large B-cell lymphoma (DLBCL) is a malignancy of immense biological and clinical
heterogeneity. Based on the transcriptomic or genomic approach, several different …
heterogeneity. Based on the transcriptomic or genomic approach, several different …
Perspectives on Current Challenges and Emerging Approaches for Lymphoma Management From the 1st Bridging the Gaps in Leukemia, Lymphoma, and Multiple …
AV Danilov, C Sauter, T Philips, CC Coombs… - … Myeloma and Leukemia, 2025 - Elsevier
Recent years have brought a much-needed paradigm shift to the management and
treatment of mature B-cell lymphomas. Pathophysiologic and clinical heterogeneity within …
treatment of mature B-cell lymphomas. Pathophysiologic and clinical heterogeneity within …
Targeting refractory diffuse large B cell lymphoma by CAR-WEE1 T-cells: In vitro evaluation
Abstract Refractory Diffuse Large B-cell Lymphoma (DLBCL) presents a major therapeutic
challenge due to its resistance to standard treatments. Engineered T-cells, especially …
challenge due to its resistance to standard treatments. Engineered T-cells, especially …
[引用][C] Introduction to series: Diffuse large B-cell lymphoma.
SM Smith, L Pasqualucci - Seminars in Hematology, 2024 - europepmc.org
Introduction to series: Diffuse large B-cell lymphoma. - Abstract - Europe PMC Sign in | Create
an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us …
an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us …